HIDRADENITIS SUPPURATIVA

This early-stage study is testing a new personalized cell therapy called SBT777101 in adults with moderate-to-severe hidradenitis suppurativa (HS), a painful chronic skin condition. Researchers will give single doses to 24 participants to check if the treatment is safe and how th…

This study is testing whether lutikizumab injections can help adults with moderate-to-severe hidradenitis suppurativa, a painful inflammatory skin condition. The trial focuses on people who haven't gotten enough benefit from standard anti-TNF medications. Participants receive wee…

This study is testing the long-term safety of bimekizumab, a medication for moderate to severe hidradenitis suppurativa (a painful skin condition). It follows 658 participants who previously completed earlier bimekizumab studies to monitor side effects over extended treatment. Th…

This study is testing five different new drugs to see if they can help people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. About 248 participants received either one of the test drugs or a placebo for 16 weeks, and researchers tracked whether t…

This study is testing whether an investigational drug called AVTX-009 can reduce painful skin lesions in people with moderate-to-severe hidradenitis suppurativa. About 250 participants will receive either the drug or a placebo for 16 weeks to see which is more effective and safe.…

This study aimed to test whether Botox injections could help control hidradenitis suppurativa, a painful skin condition that causes recurring abscesses and nodules. The trial planned to enroll people with active underarm lesions to see if Botox could reduce the number and severit…

This study is testing whether anifrolumab, an existing immune-system drug, can help control hidradenitis suppurativa (HS), a chronic inflammatory skin condition. Fifteen adults with moderate-to-severe HS will receive the drug intravenously over 24 weeks, followed by monitoring. R…

This study is testing an investigational drug called tulisokibart for people with moderate to severe hidradenitis suppurativa (HS), a chronic, painful skin condition. The main goal is to see if the drug can reduce the number of painful abscesses and nodules by at least 50% after …

This study aims to find out if people with moderate to severe hidradenitis suppurativa (HS) who improved on a medication called secukinumab should continue treatment or can safely take a break. About 700 participants who already responded to the drug in earlier studies will be ra…

This study aims to learn about the long-term safety and effectiveness of an investigational drug called sonelokimab for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. It is open to about 835 people who have already taken part in a previous…

This study is testing an investigational drug called eltrekibart for adults with moderate-to-severe hidradenitis suppurativa (HS), a painful chronic skin condition. The main goal is to find the safest and most effective dose and dosing schedule to reduce the number of painful abs…

This study is testing whether an oral drug called brensocatib can reduce painful lumps and abscesses in adults with moderate to severe hidradenitis suppurativa, a chronic inflammatory skin disease. About 214 participants will receive either the drug or a placebo for 16 weeks to s…

This study aimed to test a special laser for improving the look and feel of scars left by hidradenitis suppurativa (HS), a chronic skin condition. It planned to enroll up to 19 adults with HS scars in their underarm area who were not currently experiencing active flare-ups. Parti…

This study aims to understand how patients with hidradenitis suppurativa (HS) feel their symptoms change over time after starting the medication secukinumab. It will follow 192 adults in France for up to two years, focusing on their personal ratings of pain, skin drainage, and od…

This study aimed to see if applying a common antiseptic dye called gentian violet could help people with hidradenitis suppurativa (HS), a painful and chronic skin condition. Researchers planned to survey patients about their pain, skin redness, and drainage before and after a sin…

This study aims to understand how doctors in Germany adjust the dose of the approved drug secukinumab for adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. It will observe 424 patients over two years during their routine treatment, tracking w…